Registry of Arterial Hypertension

Overview

The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population. The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations. The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice. Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.

Full Title of Study: “Registry of Arterial Hypertension: “Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment””

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: December 1, 2023

Detailed Description

The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension

Clinical Trial Outcome Measures

Primary Measures

  • Number of patients with blood pressure <140/90 mm Hg
    • Time Frame: 2018 – 2021 years
    • The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.

Secondary Measures

  • Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.
    • Time Frame: 2018-2021
    • Diagnosis data is entered by doctors as a “yes” or “no” category.
  • Antihypertensive medications
    • Time Frame: 2018-2021
    • Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages

Participating in This Clinical Trial

Inclusion Criteria

The diagnosis of arterial hypertension - Exclusion Criteria:

No diagnosis of arterial hypertension -

Gender Eligibility: All

Participant eligibility is based on self-representation of gender identity

Minimum Age: 18 Years

Maximum Age: 99 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
  • Provider of Information About this Clinical Study
    • Principal Investigator: Irina E. Chazova, scientific researcher, Department of Hypertension, Institute of Clinical Cardiology named after A.L.Myasnikov, National Medical Research Center of Cardiology of the Ministry of Healthcare of the Russian Federation – Federal State Budgetary Scientific Institution, Research Institute of Cardiology
  • Overall Contact(s)
    • Anna Aksenova, MD, +74954146186, aksenovaannav@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.